DB
EDSA icon

Danske Bank’s Edesa Biotech EDSA Stock Holding History

Danske Bank’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8 Hold
1
– – ﹤0.01% 1071
2026
Q1 		$5 Hold
1
– – ﹤0.01% 1104
2025
Q4 		$1 Hold
1
– – ﹤0.01% 1550
2025
Q3 		$2 Hold
1
– – ﹤0.01% 1469
2025
Q2 		$2 Hold
1
– – ﹤0.01% 1499
2025
Q1 		$2 Hold
1
– – ﹤0.01% 1341
2024
Q4 		$2 Hold
1
– – ﹤0.01% 1380
2024
Q3 		$4 Buy
+1
New +$5 ﹤0.01% 1554

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Danske Bank's EDSA Position: Q2 2026 in Review

Danske Bank held its Edesa Biotech (EDSA) position steady in Q2 2026 at 1 share worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Danske Bank first reported a position in EDSA in Q3 2024 and has held it in 8 quarters since. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • Danske Bank held 1 share of Edesa Biotech worth $8 as of Q2 2026.
  • Danske Bank left its Edesa Biotech share count unchanged in Q2 2026.
  • Edesa Biotech made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1071 holding.
  • Danske Bank first reported a position in Edesa Biotech in Q3 2024 and has held it in 8 quarters since.
  • 33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.